Avalo Therapeutics

Mittie Doyle sold 3,000 shares of AVTX on 15 May. They now own 3,622 AVTX shares, or a 45% holding decrease.

Christopher Ryan Sullivan sold 18,606 shares of AVTX on 7 May. They now own 423 AVTX shares, or a 98% holding decrease.

Mittie Doyle sold 1,679 shares of AVTX on 5 May. They now own 3,622 AVTX shares, or a 32% holding decrease.

Paul Varki sold 75,063 shares of AVTX on 6 May. They now own 3,634 AVTX shares, or a 95% holding decrease.

Christopher Ryan Sullivan sold 47,000 shares of AVTX on 6 May. They now own 423 AVTX shares, or a 99% holding decrease.

Mittie Doyle sold 106,555 shares of AVTX on 6 May. They now own 3,622 AVTX shares, or a 97% holding decrease.

Mitchell Chan sold 3,167 shares of AVTX on 6 May. They now own 3,166 AVTX shares, or a 50% holding decrease.

Christopher Ryan Sullivan sold 8,458 shares of AVTX on 29 April. They now own 8,880 AVTX shares, or a 49% holding decrease.

Christopher Ryan Sullivan sold 8,457 shares of AVTX on 30 April. They now own 423 AVTX shares, or a 95% holding decrease.

Mittie Doyle sold 3,970 shares of AVTX on 6 April. They now own 3,622 AVTX shares, or a 52% holding decrease.

Christopher Ryan Sullivan sold 7,979 shares of AVTX on 1 April. They now own 25,318 AVTX shares, or a 24% holding decrease.

Mittie Doyle sold 679 shares of AVTX on 1 April. They now own 3,622 AVTX shares, or a 16% holding decrease.

Christopher Ryan Sullivan sold 7,980 shares of AVTX on 2 April. They now own 17,338 AVTX shares, or a 32% holding decrease.

Mittie Doyle sold 25,492 shares of AVTX on 16 March. They now own 3,622 AVTX shares, or a 88% holding decrease.

Jonathan Goldman sold 11,367 shares of AVTX on 14 November. They now own 0 AVTX shares, or a 100% holding decrease.